Metformin decreases the amount of glucose the liver produces, which lowers blood glucose levels. To help manage blood sugar levels, a person can drink water, including flavored, sugar-free water, and herbal teas.

Learn more about the best and worst drinks for people with diabetes. This is because the body can make insulin but does not respond well to it.

In type 2 diabetes, insulin can help the body use glucose for energy. Diabetes is a life changing condition that requires careful blood sugar management and healthy lifestyle strategies for a person to manage it safely. There are several types of diabetes.

Type 1 occurs when the body does not produce insulin. Depending on the type of diabetes, people may need to administer insulin and take other medications to manage their condition and improve glucose absorption. If a person is living with prediabetes, they can reduce the risk of developing type 2 diabetes through regular exercise and a balanced diet.

The complications of diabetes can be severe, including kidney failure and stroke, so managing the condition is vital. Read this article in Spanish. Diabetes can affect women in different ways than men. During pregnancy, around menopause, and at other times of life, women may experience specific….

Some people with diabetes need insulin injections, but others can manage the condition with oral or other injectable medications.

Learn more here. A person can manage their diabetes by making healthful changes to their diet, exercising frequently, and regularly taking the necessary medications…. Researchers said baricitinib, a drug used to treat rheumatoid arthritis, showed promise in a clinical trial in helping slow the progression of type 1….

A new review indicates that insulin—used to manage diabetes—can be kept at room temperature for months without losing its potency. My podcast changed me Can 'biological race' explain disparities in health?

Why Parkinson's research is zooming in on the gut Tools General Health Drugs A-Z Health Hubs Health Tools Find a Doctor BMI Calculators and Charts Blood Pressure Chart: Ranges and Guide Breast Cancer: Self-Examination Guide Sleep Calculator Quizzes RA Myths vs Facts Type 2 Diabetes: Managing Blood Sugar Ankylosing Spondylitis Pain: Fact or Fiction Connect About Medical News Today Who We Are Our Editorial Process Content Integrity Conscious Language Newsletters Sign Up Follow Us.

Medical News Today. Health Conditions Health Products Discover Tools Connect. Diabetes types and treatments. Medically reviewed by Kelly Wood, MD — By Rachel Nall, MSN, CRNA — Updated on February 13, Type 1 diabetes. Type 2 diabetes. Gestational diabetes. Other types of diabetes.

How insulin problems develop. Exercise and diet tips. Using insulin. Other medications. Self-monitoring tips. Frequently asked questions. How we reviewed this article: Sources.

Medical News Today has strict sourcing guidelines and draws only from peer-reviewed studies, academic research institutions, and medical journals and associations. We avoid using tertiary references.

We link primary sources — including studies, scientific references, and statistics — within each article and also list them in the resources section at the bottom of our articles.

You can learn more about how we ensure our content is accurate and current by reading our editorial policy. Share this article. Latest news Ovarian tissue freezing may help delay, and even prevent menopause. RSV vaccine errors in babies, pregnant people: Should you be worried?

Scientists discover biological mechanism of hearing loss caused by loud noise — and find a way to prevent it. How gastric bypass surgery can help with type 2 diabetes remission.

Atlantic diet may help prevent metabolic syndrome. Related Coverage. How does diabetes affect women? Medically reviewed by Suzanne Falck, MD.

Non-insulin drugs for treating type 2 diabetes Some people with diabetes need insulin injections, but others can manage the condition with oral or other injectable medications.

READ MORE. How to manage diabetes. Medically reviewed by Maria S. However, limitations exist in diagnosing prediabetes, with different cutoffs for fasting glucose and HbA1c.

Thus, other methods are needed to identify high-risk groups. Prediabetes remains challenging to diagnose due to its obscurity Lack of consensus on prediabetes diagnosis poses challenges in estimating prevalence across populations.

Future research should focus on more sensitive, specific biomarkers. Optimizing glucose and HbA1c thresholds and dynamic monitoring are needed to diagnose prediabetes accurately.

Exploring optimal strategies to prevent and control prediabetes is important to lower type 2 diabetes risk. This process enables determining whether an individual belongs to a high-risk group or requires further assessment and management. Several factors influence this decision-making process, including specific patient characteristics, additional clinical considerations, and the incorporation of relevant guidelines or policies.

Constructing a comprehensive framework for the decision-making mechanism facilitates a deeper understanding of the potential diagnostic indicators and their practical application in clinical practice. This framework enables healthcare professionals to integrate various factors and considerations, empowering them to make informed decisions and provide tailored interventions and management strategies that address the unique needs of each individual.

In summary, international consensus on prediabetes diagnosis, strategies, and more personalized, precise prevention and treatment plans is critical to addressing rising type 2 diabetes incidence.

Further inquiries can be directed to the corresponding authors. JZ: Conceptualization, Writing — original draft. The work was supported by the Scientific and technological innovation project of the China Academy of Chinese Medical Sciences CIA The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet London England — doi: PubMed Abstract CrossRef Full Text Google Scholar. GBD Diabetes in the Americas Collaborators. Burden of diabetes and hyperglycaemia in adults in the Americas, a systematic analysis for the Global Burden of Disease Study Lancet Diabetes Endocrinol 10 9 — Xie J, Wang M, Long Z, Ning H, Li J, Cao Y, et al.

Global burden of type 2 diabetes in adolescents and young adults, systematic analysis of the Global Burden of Disease Study BMJ Clinical Res ed e CrossRef Full Text Google Scholar. Lee E. Diabetes: screening, diagnosis, and prevention of type 2 diabetes.

FP essentials — PubMed Abstract Google Scholar. Babey SH, Wolstein J, Diamant AL, Goldstein H. Prediabetes in California: nearly half of California adults on path to diabetes. Policy Brief UCLA Center Health Policy Research Pb :1—8.

Google Scholar. Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in JAMA 24 — Bhattacharyya OK, Shah BR, Booth GL.

Management of cardiovascular disease in patients with diabetes: the Canadian Diabetes Association guidelines. CMAJ 9 —6. Huang Y, Cai X, Qiu M, Chen P, Tang H, Hu Y, et al. Prediabetes and the risk of cancer: a meta-analysis.

Diabetologia 57 11 —9. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Rooney MR, Fang M, Ogurtsova K, Ozkan B, Echouffo-Tcheugui JB, Boyko EJ, et al. Global prevalence of prediabetes. Diabetes Care 46 7 — Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S.

Diagnosis and management of prediabetes: A review. JAMA 14 — Edwards CM, Cusi K. Prediabetes: A worldwide epidemic. Endocrinol Metab Clinics North A 45 4 — ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes Diabetes Care 46 Suppl.

Bergman M, Buysschaert M, Ceriello A, Hussain A, Mohan V, Sesti G, et al. Current diagnostic criteria identify risk for type 2 diabetes too late. Lancet Diabetes endocrinol 11 4 —6. Mutie PM, Pomares-Millan H, Atabaki-Pasdar N, Jordan N, Adams R, Daly NL, et al.

An investigation of causal relationships between prediabetes and vascular complications. Nat Commun 11 1 Pareek M, Bhatt DL, Nielsen ML, Jagannathan R, Eriksson KF, Nilsson PM, et al.

Enhanced predictive capability of a 1-hour oral glucose tolerance test: A prospective population-based cohort study. Diabetes Care 41 1 —7. Ahuja V, Aronen P, Pramodkumar TA, Looker H, Chetrit A, Bloigu AH, et al.

Accuracy of 1-hour plasma glucose during the oral glucose tolerance test in diagnosis of type 2 diabetes in adults: A meta-analysis. Diabetes Care 44 4 —9.

Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53 Suppl 3 :S16— Wang G, Sander M. A multi-omics roadmap of β-cell failure in type 2 diabetes mellitus. Nat Rev Endocrinol 17 11 —2.

Liu Y, Xiao X, Sun C, Tian S, Sun Z, Gao Y, et al. Ideal glycated hemoglobin cut-off points for screening diabetes and prediabetes in a Chinese population.

J Diabetes Invest 7 5 — Vajravelu ME, Lee JM. Identifying prediabetes and type 2 diabetes in asymptomatic youth: should HbA1c be used as a diagnostic approach?

Curr Diabetes Rep 18 7 Du TT, Yin P, Zhang JH, Zhang D, Shi W, Yu XF. Comparison of the performance of HbA1c and fasting plasma glucose in identifying dysglycaemic status in Chinese high-risk subjects.

Clin Exp Pharmacol Physiol 40 2 —8. Ho-Pham LT, Nguyen UDT, Tran TX, Nguyen TV. Discordance in the diagnosis of diabetes: Comparison between HbA1c and fasting plasma glucose. PLoS One 12 8 :e Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS.

Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 33 10 —9. Nowicka P, Santoro N, Liu H, Lartaud D, Shaw MM, Goldberg R, et al. Utility of hemoglobin A 1c for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care 34 6 — Heianza Y, Hara S, Arase Y, Saito K, Fujiwara K, Tsuji H, et al.

Nichols GA, Hillier TA, Brown JB. Progression from newly acquired impaired fasting glusose to type 2 diabetes. Diabetes Care 30 2 — Chu X, Feng B, Ge J, Guo L, Huo Y, Ji L, et al. Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus edition.

Cardiol Plus 7 4 — Ali MK, Pearson-Stuttard J, Selvin E, Gregg EW. Interpreting global trends in type 2 diabetes complications and mortality. Diabetologia 65 1 :3— Zheng Y, Ley SH, Hu FB.

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14 2 — Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker.

Endocrine J 57 9 — Prevent type 2 diabetes in kids. August 10, Children and adolescents: standards of medical care in diabetes— Zeitler P, Hirst K, Pyle L, et al; TODAY Study Group.

A clinical trial to maintain glycemic control in youth with type 2 diabetes. Prevention or delay of type 2 diabetes: standards of medical care in diabetes— Dabelea D, Mayer-Davis EJ, Saydah S, et al; SEARCH for Diabetes in Youth Study. Prevalence of type 1 and type 2 diabetes among children and adolescents from to Arslanian S, Bacha F, Grey M, Marcus MD, White NH, Zeitler P.

Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association. Hannon TS, Dugan TM, Saha CK, et al.

Effectiveness of computer automation for the diagnosis and management of childhood type 2 diabetes. DuBose KD, Cummings DM, Imai S, Lazorick S, Collier DN. Development and validation of a tool for assessing glucose impairment in adolescents.

Pinhas-Hamiel O, Dolan LM, Daniels SR, et al. Increased incidence of non—insulin-dependent diabetes mellitus among adolescents. Ball GD, Huang TT, Gower BA, et al. Longitudinal changes in insulin sensitivity, insulin secretion, and beta-cell function during puberty. Amiel SA, Sherwin RS, Simonson DC, et al.

Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement.

Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. Screening for gestational diabetes: US Preventive Services Task Force recommendation statement.

Jones KL, Arslanian S, Peterokova VA, et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Savoye M, Caprio S, Dziura J, et al. Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial.

USPSTF Review: Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents. This systematic review to support the USPSTF Recommendation Statement summarizes published evidence on the benefits and harms of screening children and adolescents for prediabetes and type 2 diabetes.

Daniel E. Jonas, MD, MPH; Emily B. Vander Schaaf, MD, MPH; Sean Riley, MA, MSc; Bianca A. Allison, MD, MPH; Jennifer Cook Middleton, PhD; Claire Baker; Rania Ali, MPH; Christiane E.

Voisin, MSLS; Erin S. LeBlanc, MD, MPH. Recommendations for Screening Children and Adolescents for Prediabetes and Type 2 Diabetes. Patient Information: Screening for Type 2 Diabetes in Children and Adolescents.

This JAMA Patient Page describes the condition of prediabetes and its symptoms, diagnosis, and management strategies. Amy S. Shah, MD, MS; Kristen J. Nadeau, MD, MS; Megan M. Kelsey, MD, MS. See More About Diabetes Diabetes and Endocrinology Adolescent Medicine Guidelines United States Preventive Services Task Force Pediatrics.

Select Your Interests Select Your Interests Customize your JAMA Network experience by selecting one or more topics from the list below. Save Preferences. Privacy Policy Terms of Use. This Issue. Views 41, Citations View Metrics. X Facebook More LinkedIn. Cite This Citation US Preventive Services Task Force.

September 13, Article Information. visual abstract icon Visual Abstract. Summary of Recommendation. USPSTF Assessment of Magnitude of Net Benefit. Practice Considerations.

Patient Population Under Consideration. Definitions of Prediabetes and Type 2 Diabetes. Screening Tests. Treatment and Preventive Interventions. Suggestions for Practice Regarding the I Statement. Potential Preventable Burden. Potential Harms. Other Related USPSTF Recommendations.

Supporting Evidence.